Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mantle Biotech is a biotechnology company focused on a proprietary protein engineering platform known as Mantle (Molecular Antigen-binding Layer). This technology enables the development of high-affinity binding reagents that can be used for both sensitive diagnostics and potential therapeutic applications. The company's lead efforts have centered on creating rapid, low-cost diagnostic tools for infectious diseases, specifically targeting tuberculosis and COVID-19. By optimizing the interface between biological recognition elements and diagnostic surfaces, Mantle Biotech seeks to improve the speed and accuracy of disease detection in resource-limited settings. The platform's versatility allows for the rapid adaptation of binding layers to various pathogens and biomarkers, making it a robust tool for global health challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mantle Biotech.